About Us

At Algocell, we are setting new standards in bioprocess optimization, driven by a visionary team and cutting-edge technology

Our Vision

To become an industry leader in the field of Bioprocess 4.0. Fostering the bioprocess revolution through the integration of a software platform that combines Hybrid Models, Digital Twin, and Model-Based AI technologies, allowing all cell-based companies worldwide to achieve their fullest potential.

Our Mission

We are committed to accelerating the bioprocess revolution by empowering cell-based companies to achieve their objectives with fewer experiments, optimize their bioprocess performance, and implement model-based control and optimization during production to maximize productivity while ensuring consistent quality. By building a versatile and adaptable software platform, we ensure our technology has a transformative impact across various sectors, including novel foods, pharmaceuticals, agriculture, bioplastics, biofuels, and more.

Our Expertise

Our team is made of a dynamic blend of business leadership, biology, software, algorithms and data science. We push the boundaries of what’s possible in biology. As a team, we created an AI-driven, data-centric bioprocess analytics platform that is at the forefront of the bioprocess revolution, helping our clients achieve excellence and success.

Team Algocell

Omri Schanin

CEO and Co-Founder

Eyal Betzalel

CTO and Co-Founder

David Almagor PhD

Chairman and Co-Founder

Daniel Plaksin PhD

VP Biology

Nadav Schneider

Software Engineer